Webcast

NOTE: Webcast must be viewed in its entirety in order to receive full credit

Release Date: 04/06/18
Expiration Date: 04/06/19

Estimated Time to Complete Activity: 1.0 hours

Clinical Updates in the Management of HCV

David Bernstein, MD

Vice Chair of Medicine for Clinical Trials
Chief of Hepatology and Director, Sandra Atlas Bass Center for Liver Diseases
Northwell Health
Professor of Medicine
Hofstra Northwell School of Medicine
Roslyn, NY

Target Audience - This activity has been designed to meet the educational needs of gastroenterologists, nurse practitioners and physician assistants who will be screening for, referring and treating for HCV and liver disease.

Statement of Need - The purpose of the activity to provide strategies to prevent disease, educate health care providers about the disease, increase disease surveillance, and improve the therapeutic management and patient outcomes.

Learning Objectives

Demonstrate proper patient selection for HCV screening based on careful consideration of risk and benefit and published guidelines

Assess advances in HCV treatment with emphasis on safety and efficacy for better patient outcomes

Accreditation Statement - This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Empire Liver Foundation (ELF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement -The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosure Statement
David Bernstein, MD has no financial relationships to disclose.

Disclosure of Conflicts of Interest
All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., John Bayliss, VP, Business Development, Annenberg Center, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower and the Empire Liver Foundation here have no relationships to disclose.

Learner Assurance Statement:
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Commercial Support - This activity is supported from independent educational grants from AbbVie and Gilead.